Among CD4+ T cell subpopulations, CD4+CD25+Foxp3+ regulatory T cells (Tregs) represent a limited valuable subpopulation in RA treatment, and the balance of Th17 cells and Tregs is an important factor associated with the development of inflammation (1, 3). Here, CD4 is linked to rheumatoid arthritis.